Delivery Order SPE2DR25D3501-SPE2DR26FM3QV
- Not listed
- On January 29, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $9,895.28 to AmerisourceBergen Drug Corp for Apretude ER 600 mg/3 mL vials. This firm fixed-price delivery order is scheduled for completion by February 20, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $4,947.64 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Apretude ER 600mg. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of February 2, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,400.24 contract is for the delivery of APRETUDE ER 600 MG/3 ML VIAL 3 ML pharmaceutical products, with a performance period through March 13, 2024. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,942.03 by the Defense Logistics Agency's Medical Supply Chain on January 26, 2026, with completion scheduled for January 27, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting open and competitive procurement. This award is issued under Amerisourcebergen's parent company Cencora,...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $40,308.30 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. This delivery order is issued under Amerisourcebergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under a larger indefinite delivery contract vehicle. The award is part of AmerisourceBergen's...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,098.09 on January 12, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-competitive delivery order is scheduled for ultimate completion by January 13, 2026, and represents a task order under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award does not carry a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,605.68 on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded by the Defense Logistics Agency's Medical Supply Chain in support of federal medical procurement needs. The contract represents a task order issued under AmerisourceBergen's parent company Cencora,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,180.32 by the Defense Logistics Agency on January 12, 2026. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 12, 2026. This award was made on a competitive basis with no set-aside designation, reflecting the contractor's capability to compete in open federal procurement. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $1,619.64 from the Defense Logistics Agency's Medical Supply Chain on February 2, 2026. This firm fixed-price delivery order, with an ultimate completion date of February 3, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM3QVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for the supply of Apretude ER 600 mg/3 mL vials. The contract is a firm fixed-price delivery order valued at $4,947.64 with an ultimate completion date of February 24, 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This award was issued without a set-aside designation, indicating the procurement was conducted through full and open competition. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. The IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen fulfills critical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 2/1/26 |